How is oxidative stress measured?

How is oxidative stress measured?

Oxidative stress is measured by quantifying specific biomarkers in biological samples—such as blood, urine, or tissue—that reflect either the production of reactive oxygen species (ROS) or the resulting oxidative damage to lipids, proteins, and DNA. Common markers include malondialdehyde (MDA) for lipid peroxidation, glutathione (GSH) for antioxidant capacity, and enzyme activities like superoxide dismutase (SOD) and glutathione peroxidase (GPX). These measurements are typically performed using spectrophotometry, high-performance liquid chromatography (HPLC), or enzyme-linked immunosorbent assay (ELISA).

In research settings, oxidative stress is often assessed alongside clinical outcomes to explore associations with disease states or interventions. For example, trials in hypothyroidism, polyendocrine metabolic ovarian syndrome, and peripheral artery disease employ such markers to evaluate the impact of supplements or therapies [1][2][3].

Research Studies

Vitamin E and oxidative stress markers in levothyroxine-treated hypothyroidism

A clinical trial is investigating whether vitamin E supplementation as an adjunct to levothyroxine therapy reduces oxidative stress and improves antioxidant defence mechanisms in patients with hypothyroidism. The study aims to establish an evidence-based framework for integrating targeted antioxidant therapies into standard management [1].

Zinc supplementation and insulin resistance in polyendocrine metabolic ovarian syndrome

In women with polyendocrine metabolic ovarian syndrome (PMOS), a trial is evaluating the effect of zinc supplementation on insulin resistance and clinical features. Zinc is structurally required for pancreatic β-cell insulin synthesis and modulates insulin-receptor signaling; the study focuses on South Asian women, including Bangladeshi women, who develop insulin resistance at lower BMI thresholds and have a high burden of zinc deficiency [2].

Nicotinamide riboside and walking performance in peripheral artery disease

The NICE-PAD II trial is testing whether nicotinamide riboside (NR) improves six-minute walk distance in people with peripheral artery disease (PAD) aged 50 and older. Secondary outcomes include walking impairment questionnaire scores and calf muscle perfusion, with oxidative stress potentially implicated in the pathophysiology [3].

N-acetylcysteine and repetitive behaviors in Cornelia de Lange syndrome

A randomized cross-over pilot trial is assessing the efficacy of N-acetylcysteine (NAC) for repetitive behaviors and self-injurious behavior in patients with Cornelia de Lange syndrome (CdLS). NAC is described as a known anti-oxidative stress and neuroprotective agent, and has shown partial response in trials for compulsive behaviors in obsessive-compulsive disorder and related disorders in autism [4].

GPX4 expression after Kono-S vs conventional anastomosis in Crohn's disease

This project explores how the bowel heals after surgery by examining oxidative stress markers, specifically GPX4 expression, following Kono-S anastomosis compared to conventional anastomosis in Crohn's disease. The study aims to understand why the Kono-S technique may reduce disease recurrence [5].

Light therapy and oxidative stress markers in healthy adults and type 1 diabetes

A clinical trial is evaluating the effects of low-level light therapy on cellular energy and oxidative stress in healthy adults and patients with type 1 diabetes. The study measures ATP levels, cytochrome c oxidase activity, and oxidative stress markers including glutathione and malondialdehyde in blood cells before and after light therapy [6].

Vitamin D and oxidative stress in diabetic peripheral neuropathy

Diabetic peripheral neuropathy (DPN) involves oxidative stress, chronic inflammation, and mitochondrial injury. A trial is investigating vitamin D supplementation in DPN, with oxidative stress as a potential mechanistic factor [7].

Liver-targeted therapy and oxidative stress in diabetic macular edema

Diabetic macular edema is a complication of diabetic retinopathy linked to systemic inflammation. A study is exploring integrative liver-targeted therapy using tauroursodeoxycholate or traditional Chinese medicine, with oxidative stress implicated in the neuroinflammation and vascular dysfunction observed in diabetic retinopathy [8].

Comparison of oxidative stress markers across studies

If you are reading this for personal health reasons

The compounds and therapies discussed here are sold for laboratory research only. We do not provide dosing or medical guidance. Anyone considering a compound for themselves should speak to a licensed clinician.

Sources

• [1] Vitamin E Add-On Therapy, Thyroid Function & Oxidative Stress in Levothyroxine-Treated Hypothyroidism
• [2] Effect of Zinc Supplementation on Insulin Resistance and Clinical Features in Women With Polyendocrine Metabolic Ovarian Syndrome.
• [3] The NICE-PAD II Trial
• [4] Use of N-Acetylcysteine in the Treatment of Repetitive and Self-Injurious Behaviors in Cornelia de Lange Syndrome
• [5] GPX4 Expression After Kono-S vs Conventional Anastomosis
• [6] The Effect of Light Therapy on Cellular Energy and Oxidative Stress in Healthy Adults and Type 1 Diabetic Patients
• [7] Vitamin D in Diabetic Neuropathy
• [8] Integrative Liver-Targeted Therapy for Diabetic Macular Edema: Using "Tauroursodeoxycholate" or Traditional Chinese Medicine.